-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2024.
- Dianthus Therapeutics, Inc. /DE/ Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 25.7 M shares, a 2834% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 5.15 M shares, a 489% increase from 2022.
- Dianthus Therapeutics, Inc. /DE/ annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 874 K shares, a 0.09% increase from 2021.
- Dianthus Therapeutics, Inc. /DE/ annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 873 K shares, a 98% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)